GLP 1 receptor agonists (semaglutide, tirzepatide) meaningfully influence dermatologic conditions through improved insulin sensitivity and anti inflammatory pathways. Clinical improvements have been reported in hidradenitis suppurativa, psoriasis, and Naltrexone and Naloxone are opiate antagonists but they are NOT the same. Naltrexone and Naloxone are basically the same acting drug. They both can be used to "reverse" an opiate overdose, or Long Term Outcomes of GLP 1 Therapies in Type 1 Diabetes How Long Do You Stay on Semaglutide? Treatment Timelines Have you seen these on TikTok shop? , GLP 1 patches are popping up everywhere online, promising needle free weight loss support and an easy alternative to injections. , The reality? , There are Bridging the gap between GLP1 receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide Cardiovascular Diabetology Springer Nature Link